Significant improvements in overall survival (OS) and tolerability were observed in patients receiving the combination treatment of craixivir and Trop2 antibody drug conjugate (ADC).
在接受曲拉西利布与Trop2抗体药物偶联物（ADC）联合治疗的患者中观察到总存活率（Os）和耐受性有显著改善
Significant improvements in overall survival (Os) and tolerability were observed in patients receiving a combination of tracillib and Trop2 antibody drug conjugates (ADCs)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.